A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.
复制标题

DOI:
10.1182/blood.2021012064
复制
发表时间:
2021-07-01
期刊:
影响因子:
20.3
通讯作者:
Greinacher A
Greinacher A
中科院分区:
医学1区
文献类型:
--
作者:
Handtke S;Wolff M;Zaninetti C;Wesche J;Schönborn L;Aurich K;Ulm L;Hübner NO;Becker K;Thiele T;Greinacher A

文献摘要

参考文献

被引文献

相似文献

The detection of vaccine-induced thrombosis and thrombocytopenia (VITT) is an immediate problem in many parts of the world. VITT shows striking similarities to autoimmune heparin-induced thrombocytopenia, and these conditions need to be distinguished. Handtke et al describe a functional whole-blood flow cytometry test for detection of platelet-activating anti-PF4 antibodies that may be specific for VITT. Anti-PF4 antibodies as detected by some PF4/heparin enzyme immunoassays are not specific for VITT. We provide a functional whole-blood flow cytometry test for detection of platelet-activating anti-PF4 antibodies in VITT. Vaccination is crucial in combatting the severe acute respiratory syndrome coronavirus 2 pandemic. The rare complication of thrombocytopenia and thrombotic complications at unusual sites after ChAdOx1 nCov-19 vaccination is caused by platelet-activating antibodies directed against platelet factor 4 (PF4). We present a widely applicable whole-blood standard flow cytometric assay to identify the pathogenic antibodies associated with vaccine-induced immune-mediated thrombotic thrombocytopenia (VITT) after ChAdOx1 nCov-19 vaccination. This assay will enable rapid diagnosis by many laboratories. This trial was registered at www.clinicaltrials.gov as #NCT04370119.
DOI: 10.1056/nejmoa2104840
发表时间: 2021-06-03
期刊: The New England journal of medicine
影响因子: --
作者:
Greinacher A;Thiele T;Warkentin TE;Weisser K;Kyrle PA;Eichinger S
通讯作者: Eichinger S
DOI: 10.1111/jth.14383
发表时间: 2019-03-01
影响因子: 10.4
作者:
Eekels, Julia J. M.;Althaus, Karina;Greinacher, Andreas
通讯作者: Greinacher, Andreas
DOI: 10.1056/nejmcp1411910
发表时间: 2015-07-16
影响因子: 158.5
作者:
Greinacher, Andreas
通讯作者: Greinacher, Andreas
DOI: 10.1056/nejmoa2105385
发表时间: 2021-06-10
期刊: The New England journal of medicine
影响因子: --
作者:
Scully M;Singh D;Lown R;Poles A;Solomon T;Levi M;Goldblatt D;Kotoucek P;Thomas W;Lester W
通讯作者: Lester W
DOI: 10.1111/j.1600-0609.2005.00621.x
发表时间: 2006-05-01
影响因子: 3.1
作者:
Juhl, D;Eichler, P;Greinacher, A
通讯作者: Greinacher, A